Immunome Inc. (IMNM)

CIK 1472012 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Immunome Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20261440001959173-26-006875
Aug 14, 2026SCHEDULE 13G/A0001897612-26-000609
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005205
Aug 12, 202640001808343-26-000010
Aug 12, 20261440001959173-26-005926
Aug 11, 20268-K0001193125-26-344577
Aug 11, 202610-Q0001193125-26-344636
Aug 11, 2026S-80001193125-26-344743
Aug 10, 202640001808343-26-000009
Aug 6, 20261440001628280-26-054494
Aug 6, 202640001831215-26-000005
Aug 4, 20261440001959173-26-005624
Jul 27, 202640001167496-26-000005
Jul 27, 202640001831215-26-000004
Jul 27, 202640001997584-26-000006
Jul 27, 202640002026600-26-000002
Jul 27, 202640001993684-26-000006
Jul 27, 202640001994071-26-000006
Jul 27, 202640001831144-26-000002
Jul 9, 202640001831215-26-000002
Jul 7, 202640001808343-26-000007
Jul 7, 20261440001959173-26-005148
Jul 7, 202640001997584-26-000004
Jul 6, 20261440001628280-26-047387
Jul 2, 202640001808343-26-000005